Financial Conflicts of Interest in Biomedical Research
- 19 August 1993
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (8) , 570-571
- https://doi.org/10.1056/nejm199308193290810
Abstract
Financial conflicts of interest in medicine -- what they are and how to deal with them -- constitute one of the most contentious issues in our profession. Organized medicine and its critics have debated whether clinicians should gain financially from their practice in any way other than through their direct fees or salaries for service., and the academic community and its critics have debated whether medical researchers should gain financially from companies whose products they are evaluating. Opinions vary greatly -- from those advocating that all conflicts of interest be proscribed to those arguing for disclosure and caveat emptor to those maintaining that there is no problem. There are even disagreements about the definition of a conflict of interest. Many attach qualifiers, such as “potential” or “apparent,” in an attempt, it often seems, to be delicate or nonjudgmental.Keywords
This publication has 5 references indexed in Scilit:
- Understanding Financial Conflicts of InterestNew England Journal of Medicine, 1993
- Simplicity and complexity in conflict of interestScience, 1993
- Conflict of interest. The new McCarthyism in sciencePublished by American Medical Association (AMA) ,1993
- New Information for Authors — And ReadersNew England Journal of Medicine, 1990
- Dealing with Conflicts of InterestNew England Journal of Medicine, 1984